Evidence map›Paper›PMID 22768072›Full record

ArticlePloS one2012

Influence of HAART on alternative reading frame immune responses over the course of HIV-1 infection.

Stephane Champiat, Rui André Saraiva Raposo, Nicholas J Maness, John L Lehman, Sean E Purtell, Aaron M Hasenkrug, Jacob C Miller, Hansi Dean, Wayne C Koff, Marisa Ailin Hong and 8 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
0.9field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 22 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Creation of the HIV-1 antisense geneMicrobiology spectrum · 2024
    Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 7 institutions in 2 countries.

Stephane ChampiatDivision of Experimental Medicine, Department of Medicine, University of California San Francisco, San Francisco, California, United States of America.
Rui André Saraiva Raposo
Nicholas J Maness
John L Lehman
Sean E Purtell
Aaron M Hasenkrug
Jacob C Miller
Hansi Dean
Wayne C Koff
Marisa Ailin Hong
Jeffrey N Martin
Steven G Deeks
Gerald E Spotts
Christopher D Pilcher
Fredrick M Hecht
Esper G Kallas
Keith E Garrison
Douglas F Nixon
University of California, San Francisco · USSan Francisco General Hospital · USInternational AIDS Vaccine Initiative · USSaint Mary's College of California · USInstituto Adolfo Lutz · BRUniversidade de São Paulo · BRUniversity of Wisconsin–Madison · US

Funding

Virology CoreP30AI027763 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI STEVEN Grant DEEKS · 1988 to 2026
$93.6M
Preventing the Establishment of Enfuvirtide-resistance in the Latent ReservoirK24AI069994 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI DEEKS, STEVEN GRANT · 2007 to 2016
$1.5M
NIAID NIH HHS K24 AI069994NIAID NIH HHS P30 AI027763
6 · The paper itself

Abstract

backgroundTranslational errors can result in bypassing of the main viral protein reading frames and the production of alternate reading frame (ARF) or cryptic peptides. Within HIV, there are many such ARFs in both sense and the antisense directions of transcription. These ARFs have the potential to generate immunogenic peptides called cryptic epitopes (CE). Both antiretroviral drug therapy and the immune system exert a mutational pressure on HIV-1. Immune pressure exerted by ARF CD8(+) T cells on the virus has already been observed in vitro. HAART has also been described to select HIV-1 variants for drug escape mutations. Since the mutational pressure exerted on one location of the HIV-1 genome can potentially affect the 3 reading frames, we hypothesized that ARF responses would be affected by this drug pressure in vivo. METHODOLOGY/PRINCIPAL

findingsIn this study we identified new ARFs derived from sense and antisense transcription of HIV-1. Many of these ARFs are detectable in circulating viral proteins. They are predominantly found in the HIV-1 env nucleotide region. We measured T cell responses to 199 HIV-1 CE encoded within 13 sense and 34 antisense HIV-1 ARFs. We were able to observe that these ARF responses are more frequent and of greater magnitude in chronically infected individuals compared to acutely infected patients, and in patients on HAART, the breadth of ARF responses increased. CONCLUSIONS/SIGNIFICANCE: These results have implications for vaccine design and unveil the existence of potential new epitopes that could be included as vaccine targets.

Indexed as

Antiretroviral Therapy, Highly ActiveDisease ProgressionAcute DiseaseAdultAmino Acid SequenceBase SequenceChronic Diseaseenv Gene Products, Human Immunodeficiency VirusGenome, ViralGeographyHIV-1HIV InfectionsHumansMolecular Sequence DataNucleotidesPeptidesenv Gene Products, Human Immunodeficiency VirusNucleotidesPeptides

Identifiers

PMID22768072
PMCPMC3387156
OpenAlexW2067450608

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.